Even the best investments in this highly volatile business aren’t for the faint of heart. Here’s why. Read More

The days when pharmaceutical companies ignored rare diseases because the market was too small are gone. Treating rare diseases with orphan drugs is big business. Read More

Investors seeking the “hat trick” of growth, yield and safety should consider this technology leader. Read More

Yet another round of the Federal Reserve’s so-called quantitative easing is unlikely to boost a flagging economy. But it should do wonders for the emerging market, as well as commodities such as gold and oil. Read More

The Federal Reserve's decision to print an unlimited amount of U.S. dollars may boost stock prices and President Obama's re-election chances, but the U.S. economy is the real loser. Read More

The Federal Reserve takes a forceful step, directly tying new stimulus to a recovery in US employment. Read More

Increasingly affluent consumers in emerging markets are lifting the fortunes of this Latin American brewer. Read More

Here’s how investors can profit in a “mature” industry that’s now embracing leading-edge innovation. Read More

The latest version of the popular device will attract millions of new smartphone buyers and keep current users loyal. Read More

Three partnerships have filed S-1 forms with the Securities and Exchange Commission since we last wrote about MLP IPOs. Read More